SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
28 hedge funds and large institutions have $225M invested in Sinovac Biotech, Ltd in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $184M |
|
|||
|
VC
2
Vivo Capital
Palo Alto,
California
| $38.2M |
|
|||
|
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M |
|
|||
|
AWM
4
Aprio Wealth Management
Atlanta,
Georgia
| $284K |
|
|||
5
Wells Fargo
San Francisco,
California
| $109K |
|
|||
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K |
|
|||
7
UBS Group
Zurich,
Switzerland
| $59.7K |
|
|||
8
Morgan Stanley
New York
| $59.2K |
|
|||
|
HI
9
Horizon Investments
Charlotte,
North Carolina
| $336 |
|